Indoor Biotechnologies Ltd.

What Indoor Biotechnologies Ltd. does

Indoor Biotechnologies, Inc. (commercial brand InBio) is a privately held biotechnology company founded in 1994 and headquartered in Charlottesville, Virginia, with a second laboratory in Cardiff, UK. The company specializes in molecular allergy diagnostics, building a vertically integrated portfolio around the detection and quantification of allergens in environmental, biological, and food samples. Its platform centers on proprietary panels of monoclonal antibodies coupled to Luminex xMAP multiplexing (the MARIA assay, capable of detecting up to 17 allergens simultaneously) and a simplified ELISA 2.0 kit line delivering results in two hours without overnight incubation. Supporting hardware includes the patented DUSTREAM dust collector and the Apollo ambient air sampler, and the company holds an exclusive worldwide license from Vanderbilt University for human IgE monoclonal antibodies used in QC, diagnostics, and basophil/mast cell activation work. Purified natural and recombinant allergens, including low-endotoxin LoTox variants, round out a catalog of more than 125 proteins.

InBio operates a dual revenue model combining catalog product sales and contract services. Product revenue is generated through direct e-commerce (store.inbio.com) and an authorized distributor network for purified allergens, ELISA and MARIA kits, antibodies, sampling media, and equipment such as Apollo and DUSTREAM. Service revenue comes from ISO/IEC 17025:2017 accredited testing at the US and UK labs (5- and 10-business-day standard turnaround, respectively), MARIA contract testing, an Environmental Testing Suite in Cardiff built to AHAM AC-1 standards, custom immunoassay development, preclinical CRO services for allergy immunotherapy, biomanufacturing (bacterial, yeast, and mammalian expression), and mass spectrometry on a Thermo Fisher Orbitrap/Vanquish Flex UHPLC platform. Allergen manufacturing is conducted under ISO 9001:2015 certification.

InBio serves six horizontal end markets: pharmaceutical and biotech companies developing allergy immunotherapies; in vitro diagnostics manufacturers; academic and government researchers (including NIH, CDC, FDA, HUD, and large European cohorts such as ECRHS); cleaning and consumer product R&D teams validating allergen-removal claims; industrial hygiene and indoor air quality consultants; and food safety specialists. The company's ELISA 2.0 methods for Bet v 1 and Phl p 5 are being evaluated by EDQM in the BSP090 program for inclusion in the European Pharmacopoeia, and InBio's assays are cited in over 400 scientific publications, anchoring its position as a reference supplier in molecular allergy science.

Name

Indoor Biotechnologies Ltd.

Legal name

Indoor Biotechnologies, Inc.

Website

https://inbio.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Indoor Biotechnologies (InBio) is a privately held biotech that develops and commercializes purified allergens, monoclonal antibodies, MARIA multiplex and ELISA 2.0 immunoassays, sampling equipment, and accredited contract testing services for pharma, diagnostics, academic, government, consumer-product, IAQ, and food-safety customers globally.

Ownership category

akta.pro rank

Product category

Allergy Diagnostics Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Allergen Presence & Cross-Contact Verification (ELISA/PCR; allergen cleaning validation) (AFALAHAB)

akta.pro secondary industries

Allergen Cross-Contact Environmental Verification (Protein Swabs, ELISA Swabs) (AFALAEAH), Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA), Allergy Immunotherapy Biologics (allergen extracts, desensitization) (HLAAAEAI)

Keywords

• Allergy diagnostics
• Purified allergens
• Immunoassay kits
• Environmental testing
• Allergen detection

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Purified Allergens and Proteins: Sale of natural and recombinant allergens, LoTox allergens with low endotoxin, molecular reference standards, and food protein standards. Manufactured under ISO 9001:2015 certified Quality Management System.
2. ELISA 2.0 and MARIA Kits: Sale of immunoassay kits including pre-coated ELISA plates with reagents and multiplex MARIA kits for simultaneous allergen detection. Includes PickYourPlex customization options.
3. Testing Services: Contract testing services including environmental allergen analysis, food allergen testing, endotoxin testing, enzyme testing, lab animal allergen testing, mass spectrometry, cytokine/chemokine biomarker analysis, western blotting, and viral testing. Turnaround time of 5 business days (US) and 10 business days (UK).
4. Environmental Testing Suite (ETS): Temperature-controlled facility in Cardiff, UK for testing allergen products, intervention procedures and product safety. Wet and Dry rooms designed to AHAM AC-1 standards for air purifiers, cleaning products, textiles, vacuum cleaners, and other consumer products.
5. Immunoassay Development: Custom immunoassay development services for specialized needs including both ELISA and multiplex assays. Includes assay optimization and validation.
6. Preclinical CRO Services: Contract research organization services for allergy immunotherapy development including analytical and formulation services, and custom proteomics.
7. Sampling Media and Equipment: Sale of sampling equipment including DUSTREAM collectors, Apollo air samplers, air sampling cassettes, and filters.
8. MARIA Services: Gold standard testing service using proprietary MARIA technology for simultaneous allergen detection from environmental and food samples.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Indoor Biotechnologies (InBio) manufactures and sells purified natural and recombinant allergens, antibodies, ELISA and MARIA multiplex immunoassay kits, and proprietary sampling equipment (Apollo Air Sampler, DUSTREAM Collector). The company also provides contract testing services through US and UK laboratories, including environmental allergen analysis, food allergen testing, mass spectrometry, immunoassay development, and preclinical CRO services for allergy immunotherapy development.

Product overview

InBio is a biotechnology company offering a comprehensive suite of products and services for allergen detection and analysis. The portfolio includes purified allergens (natural and recombinant, including LoTox low-endotoxin variants), antibodies, immunoassay kits (ELISA 2.0 and MARIA multiplex platforms), sampling equipment (Apollo Air Sampler, DUSTREAM Collector), and molecular reference standards. The core technology platform combines proprietary monoclonal antibodies with Luminex xMAP multiplexing for simultaneous multi-allergen detection. Services encompass environmental testing, mass spectrometry, immunoassay development, preclinical CRO, and biomanufacturing. The company serves pharmaceutical, diagnostics, academic/government research, cleaning/consumer product R&D, industrial hygiene, and food safety markets.

Differentiator

Problem solved

Functional benefit

Brands

• MARIA®: Multiplex Array for Indoor Allergens - proprietary technology combining monoclonal antibodies with Luminex xMAP® multiplexing technology for simultaneous allergen detection.
• ELISA 2.0
• DUSTREAM®
• Apollo
• LoTox™
• Human IgE mAb
• Environmental Testing Suite (ETS)

Products and services

• Purified Allergens

Quantifiable outcome

• Simultaneous detection of up to 17 allergens in a single test using MARIA technology
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• Luminex CorporationcoreTechnology or IntegrationMARIA technology uses Luminex MagPlex magnetic polystyrene microspheres internally dyed with distinct fluorophores to create up to 80 distinctly coded bead sets for multiplex allergen detection.
• Vanderbilt University / Vanderbilt University Medical Center (VUMC)coreTechnology or IntegrationExclusive worldwide license agreement for human IgE monoclonal antibody technology developed at VUMC for research and diagnostic use. These natural, high-affinity monoclonal antibodies are derived from allergic patients using proprietary methods.
• European Directorate for Quality of Medicines and HealthCare (EDQM)coreStrategic or Co-development PartnerInBio participated in the EDQM Biological Standardisation Program (BSP090) to establish reference standards for major allergens (Phl p 5a and Bet v 1) and validate standard ELISA methods for inclusion in European Pharmacopoeia.

Scale indicators5 records

Recent moves4 records

Expansion highlights6 records

Direct peers

• ALK-Abelló: Global leader in allergen immunotherapy (AIT) and allergy diagnostics, with a portfolio of standardized allergen extracts and component-resolved diagnostics. Highly comparable to InBio because both operate in molecular allergy characterization, supply reference standards to biopharma, and participate in EDQM/regulatory standardization programs for allergen-specific immunotherapy products.
• Stallergenes Greer: Specialty biopharma focused on allergen immunotherapy diagnostics and sublingual immunotherapy treatments. Comparable to InBio's pharma customer-base work — both serve immunotherapy developers needing characterized purified allergens and Molecular Reference Standards to standardize AIT products and clinical trial assays.
• R-Biopharm: Developer and supplier of ELISA and PCR-based food allergen test kits and reference materials for the food industry. Directly competes with InBio's food allergen testing kits, Food Protein Standards, and MARIA food panels in allergen quantification across complex food matrices.
• Romer Labs: Food safety diagnostics specialist offering ELISA-based allergen test kits and reference materials to the food and feed industry. Comparable to InBio's food allergen testing and reference materials business, particularly for screening and confirmatory analysis of allergens in finished food products.
• EUROIMMUN (PerkinElmer): Subsidiary of PerkinElmer producing automated immunoassays for allergy, autoimmune, and infectious disease diagnostics. Overlaps directly with InBio's allergy diagnostics focus through component-resolved IgE testing platforms and allergen-specific immunoassays used in clinical labs.

Broad incumbents

• Bio-Rad Laboratories: Life sciences instrumentation company whose Bio-Plex multiplex platform is used to run InBio's MARIA kits. Comparable as both a vendor and an adjacent competitor in clinical diagnostics, and competes broadly across immunoassay and food safety testing markets where InBio operates.
• Thermo Fisher Scientific: Largest life sciences tools and diagnostics company; supplies the Orbitrap mass spectrometry platform InBio uses for allergen proteomics and offers broad allergen and immunology reagents. Comparable because it can vertically integrate into allergen testing, mass spectrometry services, and reference standards that InBio currently provides.
• Bio-Techne: Research reagent supplier (R&D Systems, Novus Biologicals, Tocris) offering purified proteins, antibodies, and ELISA kits, including allergy-related reagents. Comparable to InBio's purified allergens and antibodies business across academic and pharmaceutical research customers, with much broader portfolio depth.

Emerging players

• HOB Biotech: China-based allergy diagnostics company specializing in component-resolved IgE testing platforms and allergen microarrays. Comparable to InBio's molecular allergy diagnostics focus with greater regional reach in Asia-Pacific, an emerging geography for allergy testing where InBio relies on distributors.
• Hycor Biomedical: Diagnostics company focused on allergy and asthma testing (e.g., NOVEOS, AgileSlide allergen-specific IgE assays). Comparable to InBio's allergy diagnostics work as a specialty immunology competitor that combines in vitro diagnostics with proprietary allergen reagents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/IndoorBiotechnologies

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indoor Biotechnologies Ltd.